Found: 5
Select item for more details and to access through your institution.
Symptomatic therapy in multiple sclerosis: Big pharma should do more -- NO.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 8, p. 978, doi. 10.1177/1352458515587930
- By:
- Publication type:
- Article
Predictors and dynamics of postpartum relapses in women with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 6, p. 739, doi. 10.1177/1352458513507816
- By:
- Publication type:
- Article
Real‐world persistence of multiple sclerosis disease‐modifying therapies.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 7, p. 1, doi. 10.1111/ene.16289
- By:
- Publication type:
- Article
The MSBase pregnancy, neonatal outcomes, and women's health registry.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/17562864211009104
- By:
- Publication type:
- Article
The MSBase pregnancy, neonatal outcomes, and women's health registry.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/17562864211009104
- By:
- Publication type:
- Article